SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Xeris Pharmaceuticals Awarded Phase I-II NIH SBIR Fast Track Grant to Advance Stable, Non-Aqueous Glucagon for Bi-Hormonal Artificial Pancreas